osaühing BIOMED is a OÜ based in Tartu linn, registry code 10003494, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €0 with employees.
Turnover
0 €
State taxes
514 €
↓ 27.0%vs Q2 2026
Labour taxes
308 €
↑ 0.0%vs Q2 2026
Employees
—
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry Scientific research and development · EMTAK 72
Revenue · 20250 €
above 5% of companies
industry median 0 € · companies in the industry: 1 073
Taxes and turnover
Q4 2023 – Q3 2026
Turnover, € Q3 2026: 0 € · industry median 14 442 € · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
State taxes, € Q3 2026: 514 € · −27.0% vs Q2 2026
Figures by quarter
Quarter
Turnover, €
State taxes, €
Labour taxes, €
Employees
Q3 2026
—
514
308
—
Q2 2026
—
704
308
—
Q1 2026
—
514
308
—
Q4 2025
—
704
308
—
Q3 2025
—
514
308
—
Q2 2025
—
704
308
—
Q1 2025
18 852
1 110
304
—
Q4 2024
5 347
1 420
267
—
Q3 2024
2 582
3 214
267
—
Q2 2024
—
429
267
—
Q1 2024
1 440
435
267
—
Q4 2023
937
429
267
—
Q3 2023
4 078
429
267
—
Q2 2023
2 948
429
267
—
Q1 2023
—
429
267
—
Q4 2022
1 569
429
267
—
Q3 2022
586
429
267
—
Q2 2022
—
429
267
—
Q1 2022
4 140
1 231
267
—
Financials by year
2016 – 2025
Revenue, € 2025: 0 € · −100.0% vs 2024 · industry median 0 € · above 5% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit, € 2025: -10 911 € · −268.4% vs 2024 · industry median 0 € · above 10% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit margin, % 2024: 193.2 % · +296.8 pp vs the year before · industry median 15.8 % · above 98% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Assets, € 2025: 37 294 € · −8.6% vs 2024Equity, € 2025: 3 081 € · −78.0% vs 2024Employees2025: 0 · industry median 1 · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Financials by year
Year
Revenue, €
Net profit, €
Labour costs, €
Assets, €
Equity, €
Employees
2025
0
-10 911
0
37 294
3 081
0
2024
3 353
6 479
0
40 805
13 992
0
2023
9 403
-9 739
0
23 682
16 782
0
2022
2 151
-15 081
0
35 870
26 521
0
2021
4 140
-14 242
0
60 178
41 602
0
2020
52 593
30 805
0
82 317
55 844
0
2019
48 747
23 030
0
48 855
44 675
0
2018
—
—
—
—
—
0
2017
—
—
—
—
—
0
2016
—
—
—
—
—
0
2015
—
—
—
—
—
0
2014
—
—
—
—
—
0
2013
—
—
—
—
—
0
2012
—
—
—
—
—
0
2011
—
—
—
—
—
1
2010
—
—
—
—
—
1
2009
—
—
—
—
—
0
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.